Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuqi Gubengao
- Development stage
- Phase 1
- Lead developer
- Yunnan Baiyao
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Fuqi Gubengao (FQGBG) is a traditional Chinese medicine (TCM) botanical paste formulation developed by the Yunnan Institute of Materia Medica and Yunnan Baiyao Group, with clinical evaluation conducted in collaboration with Xiyuan Hospital of the China Academy of Chinese Medical Sciences. It is composed of three primary herbal ingredients: FuZi (*Aconitum carmichaelii*), Wolfberry (*Lycium barbarum*), and Cinnamon (*Neolitsea cassia*). Fuqi Gubengao is designed to warm kidney yang and is primarily investigated for the treatment of nocturia associated with kidney-yang deficiency syndrome (KYDS). Its therapeutic mechanism is believed to involve the improvement of the hypothalamus-pituitary-adrenal (HPA) axis function and the enhancement of energy metabolism. A Phase I clinical trial (ChiCTR1800015840) has evaluated its safety, tolerability, pharmacokinetics, and metabolomic profiles in healthy adult subjects.
- Other names
- Fuqi Guben Gao附杞固本膏
02
Targets
ADRB3 (β3)ADRB1 (β1)
Beyond the preview
Go deeper on Fuqi Gubengao.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fuqi Gubengao.